Endocrinology News

Women who reported experiencing homelessness during the year before giving birth were more likely to have delayed prenatal care and develop hypertension, diabetes and postpartum depression vs. women who reported adequate housing, data show.

Time-restricted eating can improve the health of individuals with metabolic syndrome, who are on the precipice of type 2 diabetes, heart disease and other health complications, according to an expert.

Suicide rates for individuals diagnosed with cancer increased over the past 2 decades, according to results of a retrospective study.

SAN ANTONIO — Access to GLP-1 medications is potentially impacted by care site, payer type and demographics, highlighting gaps in care that disproportionately affect certain patient subgroups, according to a presentation at ObesityWeek.

SAN ANTONIO — Petrelintide, a novel once-weekly amylin analog, was well-tolerated in a cohort of healthy people with overweight or obesity, while conferring up to 8.6% weight loss at 16 weeks, a speaker reported.

SAN ANTONIO — Half of adolescents had two or more micronutrient deficiencies 10 years after metabolic and bariatric surgery, with deficiencies more common after Roux-en-Y gastric bypass, according to a presentation at ObesityWeek.

SAN ANTONIO — In patients with obesity, the novel triple receptor agonist retatrutide was associated with improvement in health-related quality of life vs. placebo, a speaker reported.

SAN ANTONIO — Tirzepatide demonstrated long-term weight-loss benefits and prevention of diabetes progression in patients with obesity and prediabetes, but only so long as they continued the weight-loss medication, a speaker reported.

Women with polycystic ovary syndrome who initiated any weight-loss intervention saw improvements in some glycemic and hormonal measures as well as improved menstrual frequency, data from a meta-analysis show.

SAN ANTONIO — In adolescents with obesity, GLP-1 receptor agonists were associated with lower risk for incident hypertension development 5 and 10 years after initiation vs. other anti-obesity medications, a speaker reported.